A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: think (459), believe (174), consider (1000), estimate (109), suppose (5), reason (501)

University Hospital Southampton NHS Foundation Trust Constitution

Description
Read our constitution here.
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/University-Hospital-Southampton-NHS-Foundation-Trust-Constitution.pdf

Papers Council of Governors 20 July 2022

Description
Agenda attachments 1 CoG Agenda - 20.07.2022.docx Date Time Location Chair Agenda Council of Governors 20/07/2022 14
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Council-of-Governors-20-July-2022.pdf

UHS register of interests June 2025

Description
Employee Name Aarvold, Dr Alice Beatrice Rachel Aarvold, Dr Alice Beatrice Rachel Adam, Dr Robert Dhugald (Rob) Adam, Dr Robert Dhugald
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/UHS-register-of-interests-June-2025.pdf

Annual report 2021-2022

Description
2021/22 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2021/22 Presented to Parliament
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-2021-2022.pdf

AmB-(TICE)-Carboplatin-Etoposide

Description
Chemotherapy Protocol GERM CELL Amb TICE (Part 2): Carboplatin – Etoposide phosphate Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/AmB-TICE-Carboplatin-Etoposide.pdf

Papers Trust Board - 13 May 2025

Description
Agenda Trust Board – Open Session Date Time Location Chair Apologies In attendance 13/05/2025 9:00 - 13:00 Conference Room
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-13-May-2025.pdf

Annual report 20-21

Description
2020/21 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2020/21 Presented to Parliament
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-20-21.pdf

Dexamethasone(40)-Pomalidomide

Description
Regimen Chemotherapy Protocol Myeloma Dexamethasone (40)-Pomalidomide • Myeloma – Dexamethasone (40)-Pomalidomide Indication • Pomalidomide, in combination with dexamethasone, is recommended as an
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-40-Pomalidomide.pdf

Dexamethasone(20)-Pomalidomide

Description
Chemotherapy Protocol Myeloma Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Dexamethasone (20)-Pomalidomide Indication • Pomalidomide, in combination with low‑dose dexamethasone, is recommended
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-20-Pomalidomide.pdf

Clarithromycin-Dexamethasone_40_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (40)-Pomalidomide Indication • Pomalidomide, in combination with dexamethasone, is recommended
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-40-Pomalidomide.pdf
1 to 10 of 89
Previous 1 2 3 4 5 … Next